tiprankstipranks
Advertisement
Advertisement

ENTA Stock Latest News

Enanta Pharmaceuticals Flags Ongoing Uncertainty as 2025 Risk Factors Continue to Shape 2026 Outlook
Company AnnouncementsEnanta Pharmaceuticals Flags Ongoing Uncertainty as 2025 Risk Factors Continue to Shape 2026 Outlook
25d ago
ENTA
Enanta reports Q3 EPS (67c), consensus (51c)
PremiumThe Fly
Enanta reports Q3 EPS (67c), consensus (51c)
28d ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-Earnings
Is ENTA a Buy, Before Earnings?
1M ago
ENTA
Enanta Pharmaceuticals Establishes Flexible At-The-Market Offering
PremiumCompany Announcements
Enanta Pharmaceuticals Establishes Flexible At-The-Market Offering
2M ago
8K
ENTA
Enanta Faces Patent Setback in Paxlovid Litigation
PremiumCompany Announcements
Enanta Faces Patent Setback in Paxlovid Litigation
3M ago
8K
ENTA
Enanta announces European Commission approval of Maviret
PremiumThe FlyEnanta announces European Commission approval of Maviret
3M ago
ENTA
Enanta Advances RSV Antiviral Zelicapavir to Registrational Trial
Premium
Company Announcements
Enanta Advances RSV Antiviral Zelicapavir to Registrational Trial
3M ago
8K
ENTA
Enanta to advance zelicapavir into registrational Phase 2b/3 clinical trial
Premium
The Fly
Enanta to advance zelicapavir into registrational Phase 2b/3 clinical trial
3M ago
ENTA
Enanta reports Q2 EPS (45), consensus (49c)
PremiumThe Fly
Enanta reports Q2 EPS (45), consensus (49c)
4M ago
ENTA
ENTA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ENTA Earnings this Week: How Will it Perform?
4M ago
ENTA
Enanta announces first participant dosed in Phase 1 trial of EDP-978
PremiumThe Fly
Enanta announces first participant dosed in Phase 1 trial of EDP-978
5M ago
ENTA
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
PremiumCompany Announcements
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
6M ago
8K
ENTA
Enanta initiated with a Buy at Rodman & Renshaw
PremiumThe FlyEnanta initiated with a Buy at Rodman & Renshaw
6M ago
ENTA
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
Premium
Company Announcements
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
6M ago
ENTA
Enanta Shareholders Approve Board Elections and Equity Plan
Premium
Company Announcements
Enanta Shareholders Approve Board Elections and Equity Plan
6M ago
8K
ENTA
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
PremiumRatings
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
7M ago
ENTA
Enanta files $150M mixed securities shelf
PremiumThe Fly
Enanta files $150M mixed securities shelf
7M ago
ENTA
Enanta reports Q1 EPS (42c), consensus (88c)
PremiumThe Fly
Enanta reports Q1 EPS (42c), consensus (88c)
7M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
7M ago
ENTA
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatingsEnanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
10M ago
ENTA
Enanta Pharmaceuticals Reports Progress in Drug Development
Premium
Company Announcements
Enanta Pharmaceuticals Reports Progress in Drug Development
10M ago
ENTA
Enanta reports Q4 EPS (87c), consensus ($1.01)
Premium
The Fly
Enanta reports Q4 EPS (87c), consensus ($1.01)
10M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >